Are Methylation Patterns in the KALRN Gene Associated with Cognitive and Depressive Symptoms? Findings from the Moli-sani Cohort
- PMID: 39408648
- PMCID: PMC11476580
- DOI: 10.3390/ijms251910317
Are Methylation Patterns in the KALRN Gene Associated with Cognitive and Depressive Symptoms? Findings from the Moli-sani Cohort
Abstract
The KALRN gene (encoding kalirin) has been implicated in several neuropsychiatric and neurodegenerative disorders. However, genetic evidence supporting this implication is limited and targeted epigenetic analyses are lacking. Here, we tested associations between epigenetic variation in KALRN and interindividual variation in depressive symptoms (PHQ9) and cognitive (MoCA) performance, in an Italian population cohort (N = 2409; mean (SD) age: 67 (9) years; 55% women). First, we analyzed the candidate region chr3:124584826-124584886 (hg38), within the KALRN promoter, through pyrosequencing of 1385 samples. Then, we widened the investigated region by analyzing 137 CpGs annotated to the whole gene, rescued from epigenome-wide (Illumina EPIC) data from 1024 independent samples from the same cohort. These were tested through stepwise regression models adjusted for age, sex, circulating leukocytes fractions, education, prevalent health conditions and lifestyles. We observed no statistically significant associations with methylation levels in the three CpGs tested through pyrosequencing, or in the gene-wide association analysis with MoCA score. However, we observed a statistically significant association between PHQ9 and cg13549966 (chr3:124106738; β (Standard Error) = 0.28 (0.08), Bonferroni-corrected p = 0.025), located close to the transcription start site of the gene. This association was driven by a polychoric factor tagging somatic depressive symptoms (β (SE) = 0.127 (0.064), p = 0.048). This evidence underscores the importance of studying epigenetic variation within the KALRN gene and the role that it may play in brain diseases, particularly in atypical depression, which is often characterized by somatic symptoms.
Keywords: KALRN; MoCA; PHQ9; cognitive performance; depressive symptoms; kalirin.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
References
-
- Marcora E., Carlisle H.J., Kennedy M.B. 4.32-The Role of the Postsynaptic Density and the Spine Cytoskeleton in Synaptic Plasticity. In: Byrne J.H., editor. Learning and Memory: A Comprehensive Reference. Academic Press; Oxford, UK: 2008. pp. 649–673. - DOI
-
- Russell T.A., Grubisha M.J., Remmers C.L., Kang S.K., Forrest M.P., Smith K.R., Kopeikina K.J., Gao R., Sweet R.A., Penzes P. A Schizophrenia-Linked KALRN Coding Variant Alters Neuron Morphology, Protein Function, and Transcript Stability. Biol. Psychiatry. 2018;83:499–508. doi: 10.1016/j.biopsych.2017.10.024. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
- DM 1557 11.10.2022/by Next Generation EU, in the context of the National Recovery and Resilience Plan, Investment PE8 - Project Age-It: "Ageing Well in an Ageing Society";
- AIFA-2016-02364690/AIFA - The Italian Medicines Agency - Italy
- grant nr GR-2021-12375341/A.G. was funded by the Italian Ministry of Health, Ricerca Finalizzata U40
LinkOut - more resources
Full Text Sources
Medical
